Equity Profile

COGT

Cogent Biosciences, Inc.

Health CareBiotechnology$6.4B

May5Tue

Pre-Earnings Brief

UpcomingQ1-2026Pre-Market9:00 AM EDT

Company Snapshot

Cogent Biosciences, Inc. is a biotechnology company focused on developing targeted therapies for serious diseases....

Key Metrics to Watch

EPS

Earnings per share (EPS) is a key indicator of the company's profitability and financial health.

$-0.54

Revenue

Revenue figures will provide insights into the company's sales performance and market demand for its products.

$0M

Wall Street expectations, options signals, track record, and call prep available with Pro.

COGT Q1-2026 Earnings Preview

Context

Company Snapshot

Cogent Biosciences, Inc. is a biotechnology company focused on developing targeted therapies for serious diseases. With a market cap of $6 billion, it operates in the health care sector, which is increasingly important as the demand for innovative medical solutions grows.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

13%

Avg EPS Surprise

-13.59%

Avg Stock Reaction

+3.32%

Last Quarter Recap

In the last quarter, Cogent reported an EPS of $-0.64, missing estimates by 17%. The stock reacted slightly negatively, dropping 0.19% the next day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect Cogent to report a loss of $-0.54 per share this quarter, with no revenue anticipated. The company has struggled to meet earnings expectations in recent quarters.

Bull Case

If Cogent can narrow its losses and show signs of revenue growth, it could signal a turnaround, leading to increased investor confidence.

Bear Case

Continued losses and failure to generate revenue could raise concerns about the company's viability and lead to further stock declines.

Key Metrics to Watch

EPS

$-0.54

Earnings per share (EPS) is a key indicator of the company's profitability and financial health.

Revenue

$0M

Revenue figures will provide insights into the company's sales performance and market demand for its products.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will the EPS come in better than the consensus estimate of $-0.54?

A smaller loss than expected could indicate improving financial health and boost investor confidence.

Is there any indication of revenue generation this quarter?

Even a small revenue figure could signal a positive shift in the company's market performance and growth potential.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for a smaller-than-expected loss this quarter, which could be driven by cost-cutting measures or operational efficiencies.

Supporting Evidence

The historical trend shows that even when missing, the stock has often reacted positively in the days following earnings.

Options pricing suggests a larger move than has been typical, indicating that traders may expect a surprise.

Key Risk

If the EPS comes in better than $-0.54, it could shift market sentiment significantly.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's results will be critical in determining the company's trajectory, especially given its recent struggles to meet expectations.

Bull Confirmed If

An EPS loss of less than $-0.54 and any revenue generation would confirm a bullish outlook.

Bear Confirmed If

An EPS loss greater than $-0.54 without any revenue would confirm a bearish outlook.

Pre-Earnings Positioning

Options Market

Implied Move

±10.34%

Historical Avg

±3.4%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings report.

Options are pricing ±10.3% while COGT has averaged ±3.4% over the last 8 prints — setup is pricing rich.

Detail

30d HV

51.9%

Calls (42K)P/C Ratio: 0.06Puts (21K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter miss + options pricing rich setup in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 3.6%, with a raw directional average of -1.3% (modestly negative historical bias).

Edge

Institutional Ownership

Smart-money positioning from the most recent 13F filings.

Top holders adding

Institutional

103.29%

of float

Insider

0.29%

of float

Holders

362

institutions

Top Holders· as of Dec 2025

FMR, LLC
23,086,967 sh · $849.8M
14.22%
3.0%

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Cogent beats expectations and raises guidance, history suggests the stock could rise by an average of 2.45% on the following day.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further clarity from management.

Miss

Should the company miss expectations, history suggests a potential decline of around 3.44% on the next trading day.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on cost management strategies that could impact EPS.
2Details on any partnerships or collaborations that may lead to revenue.
3Insights into product pipeline advancements and their potential market impact.
4Management's outlook on market conditions and competitive landscape.
5Any commentary on investor relations and future guidance.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

May4

GRABReported

Grab Holdings Limited

RecapView

May4

GBDCReported

Company Snapshot

Cogent Biosciences, Inc. is a biotechnology company focused on developing targeted therapies for serious diseases....

Key Metrics to Watch

EPS

Earnings per share (EPS) is a key indicator of the company's profitability and financial health.

$-0.54

Revenue

Revenue figures will provide insights into the company's sales performance and market demand for its products.

$0M

Wall Street expectations, options signals, track record, and call prep available with Pro.

COGT Q1-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

13%

Avg EPS Surprise

-13.59%

Avg Stock Reaction

+3.32%

Last Quarter Recap

In the last quarter, Cogent reported an EPS of $-0.64, missing estimates by 17%. The stock reacted slightly negatively, dropping 0.19% the next day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect Cogent to report a loss of $-0.54 per share this quarter, with no revenue anticipated. The company has struggled to meet earnings expectations in recent quarters.

Bull Case

If Cogent can narrow its losses and show signs of revenue growth, it could signal a turnaround, leading to increased investor confidence.

Bear Case

Continued losses and failure to generate revenue could raise concerns about the company's viability and lead to further stock declines.

Key Metrics to Watch

EPS

$-0.54

Earnings per share (EPS) is a key indicator of the company's profitability and financial health.

Revenue

$0M

Revenue figures will provide insights into the company's sales performance and market demand for its products.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will the EPS come in better than the consensus estimate of $-0.54?

A smaller loss than expected could indicate improving financial health and boost investor confidence.

Is there any indication of revenue generation this quarter?

Even a small revenue figure could signal a positive shift in the company's market performance and growth potential.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for a smaller-than-expected loss this quarter, which could be driven by cost-cutting measures or operational efficiencies.

Supporting Evidence

The historical trend shows that even when missing, the stock has often reacted positively in the days following earnings.

Options pricing suggests a larger move than has been typical, indicating that traders may expect a surprise.

Key Risk

If the EPS comes in better than $-0.54, it could shift market sentiment significantly.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's results will be critical in determining the company's trajectory, especially given its recent struggles to meet expectations.

Bull Confirmed If

An EPS loss of less than $-0.54 and any revenue generation would confirm a bullish outlook.

Bear Confirmed If

An EPS loss greater than $-0.54 without any revenue would confirm a bearish outlook.

Pre-Earnings Positioning

Options Market

Implied Move

±10.34%

Historical Avg

±3.4%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings report.

Options are pricing ±10.3% while COGT has averaged ±3.4% over the last 8 prints — setup is pricing rich.

Detail

30d HV

51.9%

Calls (42K)P/C Ratio: 0.06Puts (21K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter miss + options pricing rich setup in Health Care

n=30

Fade rate: 13 of 29 (45%)

Edge

Institutional Ownership

Smart-money positioning from the most recent 13F filings.

Top holders adding

Institutional

103.29%

of float

Insider

0.29%

of float

Holders

362

institutions

Top Holders· as of Dec 2025

FMR, LLC
23,086,967 sh · $849.8M
14.22%
3.0%

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Cogent beats expectations and raises guidance, history suggests the stock could rise by an average of 2.45% on the following day.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further clarity from management.

Miss

Should the company miss expectations, history suggests a potential decline of around 3.44% on the next trading day.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on cost management strategies that could impact EPS.
2Details on any partnerships or collaborations that may lead to revenue.
3Insights into product pipeline advancements and their potential market impact.
4Management's outlook on market conditions and competitive landscape.
5Any commentary on investor relations and future guidance.